Patents by Inventor Runlin Z MA

Runlin Z MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SHON AS A PROGNOSTIC BIOMARKER FOR CANCER AND AS A PREDICTOR OF RESPONSE TO ENDOCRINE THERAPY
    Publication number: 20210018504
    Abstract: The estrogen-regulated gene sequence SHON has been discovered and isolated, and found to be a novel oncogene in mammary carcinoma and significantly associated with estrogen and progesterone receptor expression in breast cancer. The invention encompasses methods for predicting the responsiveness to endocrine therapy for breast cancer and providing a prognosis for disease-free and/or distant metastasis-free survival of a cancer patient.
    Type: Application
    Filed: December 26, 2019
    Publication date: January 21, 2021
    Inventor: Runlin Z. MA
  • SHON AS A PROGNOSTIC BIOMARKER FOR CANCER AND AS A PREDICTOR OF RESPONSE TO ENDOCRINE THERAPY
    Publication number: 20170010267
    Abstract: An estrogen-regulated gene sequence SHON has been characterised, and found to be a novel oncogene in mammary carcinoma and significantly associated with estrogen and progesterone receptor expression in breast cancer. The present invention encompasses methods for predicting the responsiveness to endocrine therapy for breast cancer and providing a prognosis for disease-free and/or distant metastasis-free survival of a cancer patient.
    Type: Application
    Filed: October 17, 2013
    Publication date: January 12, 2017
    Inventors: Runlin Z MA, DONG-XU LIU